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Abstract 
The endoplasmic reticulum (ER) is the largest cellular organelle adapting dynamically to 
cope with cellular stress and high demand of newly synthesized proteins. Protein misfolding 
eventually occurs in the ER and leads to protein aggregation and ER dysfunction. Mammals 
have developed evolutionary-conserved quality control mechanisms at the ER. ER-phagy is 
a novel identified pathway targeting ER portions via autophagy for lysosomal degradation. 
This process occurs through ER-phagy receptors, ER proteins that bind autophagosomal 
LC3 protein via a cytosolic LC3 interacting domain. However, the importance of ER-phagy 
in maintaining cellular homeostasis is still undiscovered. Moreover, the molecular 
mechanisms that regulate ER-phagy according to cellular needs are still largely unknown.  
Chondrocytes and osteoblasts are highly secretory cells with an abundant ER, producing 
predominantly procollagen (PC) molecules in the extracellular matrix during endochondral 
ossification. They reside in a poorly vascularized tissue as the growth plate with scarcity of 
nutrients, representing a good cellular model to study ER-phagy. We have characterized ER-
phagy in PC producing cells, serving as a cellular pathway that selectively recognizes 
misfolded PC in the ER lumen. Specifically we found that the ER chaperone CALNEXIN 
acts as co-receptor that recognizes ER-luminal misfolded PC and interacts with the ER-
phagy receptor FAM134B. In turn, FAM134B binds the autophagosome membrane-
associated protein LC3 and delivers a portion of ER containing both CALNEXIN and PC to 
the lysosome for degradation. Moreover, we identified ER-phagy as a transcriptionally 
induced mechanism by induction of FAM134B expression during starvation and upon FGF 
signaling, a critical regulator of chondrocyte differentiation. In vivo, FAM134B knock-down 
in Medaka fish dampened cartilage growth and bone formation, suggesting a physiological 
function of ER-phagy during skeletogenesis. Taken together, these data unveil a role for 
FAM134B-dependent ER-phagy in maintaining cellular fitness in PC producing cells and 
suggest potential therapeutic approaches for the treatment of skeletal features in multiple 
human diseases. 
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Macroautophagy (referred to as autophagy) is a catabolic process dedicated to the turnover 
of intracellular components through the sequestration of cytoplasmic material in double-
membrane autophagic vesicles (AVs) that eventually fuse with lysosomes where cargo is 
degraded [1]. Proteins and organelles are selectively delivered to AVs via receptor-mediated 
processes. Autophagy receptors are constituted by a LC3 or GABARAP interaction motif 
(LIR or GIM, respectively) enabling the binding of the cargo to LC3 or GABARAP proteins, 
which decorate autophagosomal membranes [2, 3]. 
Different forms of selective autophagy exist depending on the cargo specificity mediated by 
different autophagy receptors. These forms of selective autophagy include for instance 
aggrephagy (for protein aggregates), glycophagy (for glycogen), ribophagy (for ribosomes), 
along many other types [4]. During the recent years, an additional important example of 
selective autophagy is emerging, the ER-phagy pathway, in which portions of the 
endoplasmic reticulum (ER) are sequestered within AVs and transported to the lysosomes 
for degradation.  
However, given the complexity of the ER in terms of its cellular topology and functions, 
ER-phagy is not the only quality control mechanism operating at the ER. In the next section, 
the many diverse functions of the ER will be highlighted, along with the different 
mechanisms of quality control operating at the ER. Next, ER-phagy and its role in cargo 
degradation will be discussed, with a particular emphasis on the description of molecular 
mechanisms of procollagen (PC) degradation mediated by ER-phagy.  
 
The endoplasmic reticulum (ER) as a cellular ‘hub’ 
The ER is the largest organelle in the cell involved in diverse cellular functions, including 
calcium storage, lipid and protein biosynthesis, secretion and transport [5, 6]. It is considered 
as a cellular ‘hub’ for sorting both intracellular and extracellular proteins destined to 
different compartments: i.e. Golgi, plasma membrane, extracellular matrix along with many 
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others [7, 8]. To maintain high efficiency in all the above functions, the ER needs to 
dynamically adapt to handle cellular stress conditions and high demand of newly synthesized 
proteins [9, 10]. Importantly, errors in protein synthesis and folding eventually occur and 
induce protein misfolding and aggregation, thus leading to ER stress and culminating in cell 
death [11, 12]. The disruption of cellular fitness caused by ER stress is at the basis of multiple 
human disorders, including neurodegenerative diseases, being the most frequent, or ageing 
conditions such as late-onset type 2 diabetes, atherosclerosis and cataracts among many 
others [13-16]. In fact, an impairment of ER functions or inefficiency of the cellular 
degradative mechanisms is often associated to bacterial and viral infection or to 
‘conformational diseases’ [13-15, 17-20], in which misfolded proteins aggregate at the ER 
with disruption of both cellular and tissue fitness. Notable examples are represented by 
Osteogenesis Imperfecta and Dysferlinopathy, which are caused by the accumulation of 
protein inclusions in the ER lumen (i.e. procollagen and dysferlin), in which the induction 
of autophagy has been shown to enhance their degradation and ameliorate cellular distress 
[21, 22].   
 
Quality control mechanisms operating at the ER  
Mammals have developed evolutionary-conserved and internal quality control mechanisms 
at the ER, by which newly synthesized proteins are ‘proof-read’. This mechanism allows 
that only the properly folded proteins can exit from the ER and are destined to the secretory 
pathway [23]. The best characterized of these quality control mechanisms, is the ER-
associated degradation (ERAD) pathway, a process by which folding of proteins is 
continuously monitored and misfolded polypeptides are dislocated from the ER to the 
cytosol to be degraded by the 26S proteasome [24, 25]. However, the role of additional 
quality control mechanisms is increasingly emerging, as not all misfolded ER clients are 
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eligible for ERAD, and thus must be cleared from the ER through other alternative, ERAD-
independent, processes.  
The lysosomal system is a main centre for cellular clearance, involved in the degradation 
and recycling of unwanted cytosolic material and cellular waste [26]. Up to now, an 
increasing list of misfolded proteins, including mutant forms of alpha1-antitrypsin, 
hormones or hormone receptors and proalpha1 (I) chains of type I procollagen has been 
shown to be excluded from the ERAD pathway [27-30]. Intracellular substrates are delivered 
to the lysosomes via different routes including, at least three alternative, ERAD-independent, 
pathways. In addition to the canonical ERAD pathway (A), the alternative quality control 
pathways include: B) ER-phagy (requiring macroautophagy, discussed next) [31, 32]; C) 
microautophagy [33] or D) ER-to-lysosome associated degradation (ERLAD) (Figure 1) 
[34]. As previously discussed, whereas in macroautophagy the cytosolic material is delivered 
to lysosomes via autophagosomes, in microautophagy lysosomal membranes directly engulf 
and sequester cytosolic targets for degradation, that include ER fragments or ER exit sites 
(ERES), a mechanism generally described as ‘ERES-microautophagy’ and it requires 
components of the autophagy machinery [1, 35],[36]. Conversely in the ERLAD pathway, 
the protein aggregates are first segregated in ER subdomains, then enclosed in single-
membrane ER vesicles that eventually fuse with lysosomal degradative organelle, not 
requiring autophagosomes or component of the autophagy machinery [34].  
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Figure 1. Quality control mechanisms of clearance operating at the endoplasmic 
reticulum (ER).  
A) The ER associated degradation (ERAD) requires the Translocon-Proteasome complex to 
dislocate misfolded proteins from the ER to the cytosol and degrade them, respectively. B) 
In ER‐phagy, ER fragments are sequestered by a double‐membrane autophagosome 
decorated with LC3 molecules (green dots). Autophagosomes then fuse with lysosomes for 
degradation. C) In ERES-microautophagy, lysosomal invagination or protrusion directly 
engulfs portions of ER or ER exit sites (ERES) decorated with LC3 molecules (green dots). 
D) In ER-to-lysosome associated degradation (ERLAD), single membrane ER-derived 
vesicles bud from the ER and fuse with lysosomes for degradation. Abbreviations: ER, 
endoplasmic reticulum; AV, autophagic vesicle. 
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The ‘ER-phagy’ pathway, its receptors and functions 
The term ‘ER-phagy’ was first identified in yeast for defining the process of selective 
clearance of the ER by the vacuoles (the yeast lysosome) exposed to cellular redox 
perturbations or starvation [37, 38]. Although this process was described to be autophagy-
independent [39], more recently it has been shown in yeast that ER fragments can be 
sequestered into Atg8-positive autophagosomes upon nutrient starvation or TOR inhibition 
by Rapamycin [40]. A similar process has been successively described in mammalian cells 
that during starvation induce selective engulfment of ER fragments into autophagosomes for 
lysosomal degradation [41]. 
The ER is composed of a complex structure that forms a continuous membrane network 
made of cisternae (or sheets) and tubules spreading from the nucleus to the plasma membrane 
[42]. Cisternae and tubules are mostly connected through three-way junctions, which result 
in an ER having a cellular polygonal pattern [43]. However, the complexity of ER structure 
has been further elucidated by ultra-structural studies using super-resolution electron 
microscopy, having identified membrane sheets as densely packed tubular arrays, also 
defined as ER matrix, with a rapid dynamic reorganization to allow many cellular functions 
[44]. Up to now, distinct and specialized ER-phagy receptors have been identified in 
mammals, including SEC62, CCPG1, TEX264, FAM134B, ATL3 and RTN3 [31, 41, 45-
50]. FAM134B, RTN3 and ATL3 are proteins with an intramembrane (IM) region lacking 
an ER luminal domain, having functions in shaping ER, modulating tubule/sheet ratio and 
tubule branching [51, 52]. FAM134B targets perinuclear sheets, whereas RTN3 and ATL3 
target ER tubules. On the contrary, CCPG1, SEC62 and TEX264 are transmembrane (TM) 
proteins with a cytosolic, ER-membrane and ER-luminal domains with no reported function 
in shaping ER membranes. Although transmembrane receptors are ubiquitous in the ER, 
TEX264 has been recently observed at three-way junctions suggesting that it might be 
enriched in these subdomains [53]. Notably, SEC62 is a constituent of the translocon 
 12 
 
complex regulating protein import in the mammalian ER. All ER-phagy receptors share one 
or more LC3 interaction motif (LIR) that facilitates binding of the cargo to LC3 proteins, 
which decorate autophagosomal membrane, thus leading the delivery of ER fragments to 
autophagosomes (Figure 2, Table 1) [2].  
ER-phagy is implicated in a variety of cellular functions having fundamental cytoprotective 
roles. In fact, it is involved in re-shaping ER after expansion under cellular stress and protein 
synthesis overload,  as described in B and T lymphocytes [54, 55]. SEC62-mediated ER-
phagy promotes recovery from ER stress, in a series of events called RecovER-phagy. In 
this process, ER portions are selectively cleared in order to re-establish ER homeostasis and 
chaperone content [45]. However, ER-phagy is also implicated in removing misfolded 
cargoes from the ER and controlling cellular proteostasis, a cellular process discussed next. 
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Figure 2. The ER-phagy receptors in mammals.  
The upper panel shows intramembrane receptors: FAM134B, RTN3 and ATL3 that are 
proteins with an intramembrane region lacking an ER luminal domain. The lower panel 
shows transmembrane receptors: SEC62, CCPG1 and TEX264 with a cytosolic, ER-
membrane and ER-luminal domains. All ER-phagy receptors share one or more LC3 
interaction region (LIR). CCPG1 also contains two FIP200 interaction regions (FIR). 
Abbreviations: ER, endoplasmic reticulum; N, N-terminal domain; C, C-terminal domain; 
LIR, LC3 interaction region; FIR, FIP200 interaction region.  
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Table 1. Mammalian ER-phagy receptors and their general characteristics.  
 
 
Abbreviations: IM, Intramembrane; TM, Transmembrane. 
 
 
The ER-phagy serves in the selective-mediated degradation of ER misfolded cargoes 
Another emerging function of ER-phagy is the degradation of ER portions containing 
misfolded protein clients as a back-up or alternative pathway to ERAD. The in vivo deletion 
of CCPG1 in mice is associated to the accumulation of ER insoluble proteins in exocrine 
pancreatic cells [31], thus highlighting the physiological importance of ER-phagy in 
removing aberrant protein products from the ER lumen. Moreover, the identification of 
multiple ER-phagy receptors suggests that different ER cargos might be subject to different 
types of ER-phagy.  
Up to now, FAM134B and RTN3 have emerged as the major ER-phagy receptors to have a 
fundamental role in the selective removal of specific cargoes, including i) for FAM134B, 
mutant forms of alpha1-antitrypsin Z (ATZ) and NPC Intracellular Cholesterol Transporter 
1 (NPC1) or ii) for RTN3, mutant type of proinsulin (Akita mutant) [34, 56, 57].  
 
Procollagen-selective clearance mediated by ER-phagy 
Collagens represent the most abundant molecules among the ER proteins. Type I and type 
II collagen (COL1 and COL2) are the major protein components of bone and cartilage, 
Structure Receptor Domains  
(LIR domain common to all) 
Process involvement  
at the ER 
IM FAM134B Intramembrane Reticulon-
Homology Domain (RHD)  
ER-phagy 
ERLAD 
RTN3 Intramembrane Reticulon-
Homology Domain (RHD) 
ER-phagy 
ATL3 Intramembrane Dynamin- 
like  GTPase Domain 
ER-phagy 
TM CCPG1 FIP200-interacting region  
(FIR domain) 
ER-phagy 
SEC62  RecovER-phagy  
TEX264  ER-phagy 
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respectively [58]. The biosynthesis of procollagen occurs in multiple steps, summarized in 
Figure 3.  
Procollagens (PCs) are synthesized as alpha I and alpha II chains and folded into triple 
helices of procollagen in the ER [58]. Properly folded PCs associate with the Heat Shock 
Protein 47 (HSP47) chaperone and then leave the ER through ERES sub-regions, within coat 
protein complex II (COPII) coated carriers, and move along the secretory pathway [59]. 
Previous studies demonstrated that approximately 20% of newly synthesized type I 
procollagen (PC1) is degraded by lysosomes as a consequence of inefficient PC1 folding or 
secretion; this fraction significantly increases in cases of PC1 mutations [27, 60]. Similar 
data have been observed in vivo, in which a fraction of type II procollagen (PC2) produced 
by chondrocytes of the growth plate is degraded by autophagy [61-63]. The inactivation of 
autophagy pathway results in PC2 accumulation in the ER and defective formation of the 
extracellular matrix [61, 63]. Overall, these data clearly indicate that aberrant PC molecules 
represent ERAD-resistant substrates where autophagic clearance emerges as a crucial and 
physiologically relevant event in the maintenance of cellular and organ homeostasis. 
However, to date, the mechanism by which misfolded ER luminal PC is recognized by the 
cytosolic autophagic machinery and delivered to the lysosomes remains to be understood.  
In this study, we sought to uncover the mechanisms that select non-native PC in the ER 
lumen for lysosomal delivery and clearance. We found that the misfolded PC molecules (e.g. 
HSP47 negative) are cleared from the ER through FAM134B-mediated ER-phagy. Notably, 
FAM134B binds PC molecules in the ER through the interaction with the transmembrane 
ER chaperone CALNEXIN (CANX) that acts as a specific FAM134B ER-phagy co-receptor 
for misfolded PCs. The formation of this complex allows the selective delivery of PC 
molecules to the lysosomes for degradation. 
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Figure 3. Steps for procollagen (PC) synthesis.  
Procollagen synthesis requires multiple steps: i) It is synthesized as alpha I and alpha II 
single chains by ribosomes. ii) It is folded into triple helices of procollagen (PC). iii) The 
properly folded PC associates with the Heat Shock Protein 47 (HSP47) chaperone. iv) PC 
molecules then leave the ER through ERES sub-regions, within coat protein complex II 
(COPII) coated carriers, and move along the secretory pathway. Abbreviations: ER, 
endoplasmic reticulum; PC, procollagen; ERES, ER-exit sites; COPII, coat protein complex 
II; HSP47, Heat Shock Protein 47 chaperone. 
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Autophagy promotes degradation of intracellular PCs  
Using three collagen producing cell lines, such as mouse embryonic fibroblasts (MEFs), 
human osteoblasts (Saos2) and rat chondrosarcoma cells (RCS), stably expressing the 
autophagosome membrane marker LC3 fused with GFP (GFP-LC3), we observed co-
localization of LC3 positive vesicles (hereafter referred as autophagic vesicles, AVs) with 
PC1 (MEFs and Saos2) and PC2 (RCS) (Figure 4).  
 
 
 
 
Figure 4. Procollagen is an autophagy substrate. 
(A, B) Airyscan confocal analysis of PC1 colocalization with GFP-LC3 in (A) MEF (B) 
Saos2. Scale bars = 10 µm. (C) Airyscan confocal analysis of PC2 colocalization with LC3 
in RCS cells. Scale bars = 10 µm. (D) Quantification of GFP vesicles positive for PC1 or 
PC2, expressed as % of total LC3 (mean +/- SEM), n = 18 cells (MEFs and Saos2); n=12 
(RCS) from 3 independent experiments.  
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Similarly, we observed the colocalization of PC1 spots with the GFP-tagged double FYVE 
domain–containing protein 1 (DFCP1), which labels sites for autophagosome biogenesis 
(omegasomes) (Figure 5, A-B). In vivo, osteoblasts of the mandible in Medaka fish embryos 
(stage 40), showed the presence of AVs containing PC1 molecules (Figure 5, C-E). 
 
Figure 5. PC1 is an autophagy substrate.  
(A, B) Representative immunofluorescence in (A) MEF and (B) Saos2 and quantification of 
AVs positive for GFP-DFCP1 containing PC1 expressed as % of total DFCP1 per cell (mean 
+/- SEM).  Scale bar = 10 µm. (A) n=19 and (B) n=14 cells counted per condition. N=3 
independent experiments. (C) Schematic representation of a stage 40 medaka fish. Dotted 
box represents area of mandible shown in (D and E). (D) Scanning confocal image of 
mandible from stage 40 medaka, immunostained with LC3 (488, green), PC1 (568, red) and 
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nuclei stained with Hoechst (blue). Dotted box represents area of mandible containing 
osteoblasts that was further analysed in (E). Scale bar = 20 µm. (E) Airyscan confocal image 
of mandible at higher magnification, scale bar = 3 µm. Boxes on the right show 
magnification of boxed area.  
 
 
PCs accumulate and are degraded in the lysosomes 
When MEFs, Saos2 and RCS cells were treated with the lysosomal inhibitor Bafilomycin 
A1 (BafA1), PC accumulated in the lumen of swollen endo/lysosomes (LAMP1 positive 
organelles, hereafter referred as lysosomes) (Figure 6A). Western blot analysis confirmed 
the accumulation of intracellular PCs, as well as of the autophagy markers LC3-II and 
SQSTM1, in cells treated with BafA1 compared to untreated cells (Figure 6B). BafA1 wash-
out induced a rapid clearance of PC1 and PC2 from lysosomes of MEFs and RCS, 
respectively, in line with the notion that PCs are degraded in this compartment (Figure 6C). 
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Figure 6. PCs accumulate and are degraded in the lysosomes. 
(A) Scanning confocal microscopy analysis of MEFs, Saos2 and RCS cells treated with 
BafA1, immunolabeled for PC1 or PC2 (568, red) and LAMP1 (488, green). Nuclei were 
stained with Hoechst (blue). Scale bars = 10 µm. (B) MEFs, Saos2 and RCS were untreated 
or treated with 100nM BafA1 for 6h in MEFs, 100nM BafA1 for 9h in Saos2, 200nM BafA1 
for 6h in RCS, then lysed and analysed by western blot. Bands were visualised with 
antibodies against PC1, PC2, LAMP1, SQSTM1/p62, LC3 and β-ACTIN. Western blots are 
representative of 3 independent experiments.  (B, C) (B) MEFs or (C) RCS treated with 
vehicle, 100 nM BafA1 for 4 h, followed by 4h washout. Cells immunolabeled with LAMP1 
(488, green) and PC1 or PC2 (568, red). Nuclei were stained with Hoechst (blue). Scale bars 
= 10 µm.  
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Lysosomal storage disorders (LSDs) represent genetic diseases characterized by an altered 
lysosomal degradative capacity due to mutations in genes encoding for lysosomal proteins. 
As a result, lysosomal substrates progressively accumulate within the lumen of lysosomes 
causing lysosomal swelling and cell dysfunction. We determined whether PC molecules 
accumulated in the lysosomes of LSD osteoblasts. Saos2 osteoblasts in which the alpha-L-
iduronidase gene was deleted using CRISPR-Cas9 technology (CRISPR-IDUA) represent a 
disease model of mucopolysaccharidosis type I (MPS I), a lysosomal storage disorder with 
severe skeletal manifestations [64]. Similarly, to cells treated with BafA1, CRISPR-IDUA 
showed swollen lysosomes, suggesting an accumulation of undigested substrates in the 
lysosomal lumen. Moreover, the level of PC1 in lysosomes, and in the whole cell lysate, was 
higher in CRISPR-IDUA Saos2 compared to control cells (Figure 7).  
 
Figure 7. PCs accumulate in CRISPR-CAs9 IDUA Saos2 as a prototype of LSD.   
(A) Scanning confocal microscopy analysis of Saos2 WT and CRISPR-Cas9 IDUA Saos2 at 
steady state, immunolabeled for PC1 (568, red) and LAMP1 (488, green). Nuclei were 
stained with Hoechst (blue). Scale bar = 10 µm. Bar graph shows quantification of lysosomes 
containing PC1 expressed as % of total LAMP1 per cell (mean +/- SEM). n= 31 cells counted 
per condition; 3 independent experiments. Student’s unpaired, two-tailed T-Test *** 
P<0.0001. (B) WT and CRISPR IDUA Saos2 lysed and analysed by western blot. Bands 
were visualised with antibodies against PC1, LAMP1, LC3 and β-ACTIN. Data are 
representative of 3 independent experiments.  
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Autophagy sequesters PC molecules in the ER 
A temperature shift assay was performed in order to understand at which trafficking stage 
PC became an autophagy substrate. In this assay, PC accumulates in the ER during 
incubation at 40 °C, and is released from the ER upon shift of the temperature to 32 °C. 
U2OS cells expressing GFP-LC3, mCherry-PC2 and ER marker RDEL-HALO, were 
imaged upon shift to 32 °C (time 0 sec). We observed that PC2 spots formed at the ER 
and progressively accumulated GFP-LC3 (Figure 8A).  
We also performed Correlative Light Electron Microscopy (CLEM) and electron 
tomography on GFP-LC3 expressing Saos2 cells, showing that PC1 and CANX are found 
together in a small vesicle contained within a larger LC3-positive vesicle (Figure 8B). Taken 
together these data suggest that PC molecules are sequestered within LC3-positive vesicles 
when they are still within the ER. 
 
Figure 8. Autophagy sequesters PC molecules in the ER.  
(A) U2OS expressing GFP-LC3 (green), mCherry-PC2 (red) and RDEL-HALO (blue) were 
imaged live by spinning disc microscopy. Single and merge channels time-lapse stills from 
the boxed region are shown on the right. Scale bar = 10 µm. (B) Correlative Light Electron 
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Microscopy (CLEM) and Electron Tomography of Saos2 cells transfected with GFP-LC3 
(green) and labelled for PC1 (568, red and nanogold particles) and CANX (647, blue). 
Cells were first imaged by confocal microscopy (top left panel) and then the same region 
was retraced in EM (upper middle panel) and overlay is shown (upper right panel). Arrow 
indicates a LC3 positive vesicle containing CANX and PC1 molecules. Single 
tomography slice (left panel), overlay with immunofluorescence (IF) (central panel) and 
IF 3D rendering of AV (green) and the CANX positive vesicle containing gold particles 
of labelled collagen (blue and white respectively) inside an AV (right panel).   
 
 
Mutant Procollagens are targeted to the lysosome at higher rates compared to WT 
The collagen-specific chaperone HSP47 was excluded from the AVs containing PC1 in 
MEFs (Figure 9, A-B), strongly suggesting that the autophagy sequesters non-native PC1 
molecules in the ER, in line with previous results [21, 61]. To further confirm this notion in 
a disease condition, we investigated two missense mutations in the COL2a1 protein (R789C 
and G1152D) that induce misfolding of the PC2 triple helix and accumulation within the ER 
of chondrocytes with dilated ER sheets [65]. The mutations cause a type II collagenopathy 
in humans, named Spondyloepiphyseal Dysplasia Congenita (SEDC) [66]. When expressed 
in chondrocytes the R789C- and G1152D- mutants were targeted to the lysosomes at higher 
rates compared with WT COL2. Notably, pharmacological enhancement of autophagy with 
the autophagy inducing peptide Tat-BECLIN-1 [67] increased targeting of WT and of 
mutant PC2 molecules to lysosomes. Opposite results were observed by treating cells with 
the autophagy inhibitor SAR405 (Figure 9C). Taken together these data suggest that 
autophagy preferentially degrades non-native misfolded PC molecules, preventing their 
accumulation in the ER.  
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Figure 9. Misfolded PC in the ER is targeted to lysosomes via autophagy. 
(A) DFCP1, a marker of autophagosome biogenesis co-localizes with PC1 and CANX. GFP-
DFCP1 (green) expressing MEF and Saos2 immunolabelled for PC1 (568, red) and CANX 
(647, blue). Scale bars = 10 μm. (B) HSP47 is excluded from PC1 containing 
autophagosomes. GFP-LC3 (green) expressing MEFs immunolabelled for PC1 (568, red) 
and HSP47 (647, blue). Scale bars = 10 μm. (C) RCS cells were transiently transfected with 
mCherry-PC2 WT, R789C or G1152D mutants (568, red) and treated for 6h with 100nM 
BafA1, and as indicated with SAR405 or Tat-BECLIN-1. Cells were fixed and 
immunolabelled for LAMP1 (488, green). Nuclei were stained with Hoechst (blue). Scale 
bars = 10 µm. Bar graph shows quantification of LAMP1 vesicles positive for mcherry-PC2, 
expressed as % of total lysosomes per cell (mean +/- SEM), minimum of n=11 cells per 
genotype. Two-way ANOVA with TUKEY’s post-hoc test performed and P value adjusted 
for multiple comparisons. ** P<0.005; *** P<0.0001. 
 
 
 
C 
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FAM134B is required for autophagy of procollagen 
Different autophagy-related (ATG) proteins and receptors are involved in autophagosome 
formation and cargo recognition, respectively [68].  
To characterize the autophagy machinery that enables the delivery of PC molecules to 
lysosomes, we silenced genes belonging to different functional autophagy clusters in Saos2 
cells treated with BafA1, and quantified the efficiency of PC1 delivery to the lysosomes. As 
expected, we found that the silencing of all genes tested involved in AV biogenesis 
significantly inhibited the delivery of PC1 to the lysosomes.  
Notably, among autophagy and ER-phagy receptors, we found that FAM134B silencing most 
effectively inhibited PC1 delivery to lysosomes (Figure 10A). Our siRNA data was further 
validated using MEFs knocked-out for genes involved in AV biogenesis, namely Fip200 
(Fip200–/–), Atg7 (Atg7–/–) or Atg16l (Atg16l–/–) as well as in MEFs lacking Fam134b 
expression (CRISPR Fam134b). The effect of Fam134b knockout was specific, since MEFs 
lacking Sec62 expression (CRISPR Sec62), a different ER-phagy receptor [45], showed a 
normal rate of PC1 delivery to the lysosomes (Figure 10B-D).  
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Figure 10.  FAM134B is required for autophagy recognition of PC1.  
(A). Bar graph shows quantification of lysosomes (LAMP1+) containing PC1 expressed as 
% of lysosomes (mean +/- SEM) in Saos2 cells mock transfected or transfected with SiRNA 
against the indicated genes, treated with 100 nM BafA1 for 9h. n=20 cells per condition; 
three independent experiments. One-way ANOVA (P<0.0001) with Dunnett’s multiple 
comparisons test performed, ***P<0.0001. (B) WT and KO MEFs for indicated genes were 
lysed at steady state and analysed by western blotting. Bands were visualised with antibodies 
against PC1, SQSTM1/P62, LC3, β-Actin as controls. Western blots are representative of 3 
independent experiments. (C) MEF cell lines knock-out or CRIPSR-Cas9 for indicated 
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genes were treated for 12h with 50 nM BafA1, fixed and immunolabeled for PC1 (red, 568) 
and LAMP1 (green, 488). Scale bar = 10 µm. Insets show magnification of the boxed area. 
(D) Bar graph shows quantification of LAMP1 vesicles positive for PC1, expressed as % of 
total lysosomes (mean +/- SEM), n=12, 10, 12, 10, 7, 10 cells per genotype respectively; 3 
independent experiments. One-way ANOVA with Dunnett’s multiple comparisons test 
performed and P value adjusted for multiple comparisons. *** P<0.0001.  
 
 
PC is the main substrate to accumulate in CRISPR Fam134b MEFs 
Western blot and immunofluorescence analyses confirmed the accumulation of intracellular 
PC1 in CRISPR Fam134b MEFs compared to control cells. Notably, there was not a 
generalized accumulation of other ER proteins (VAPA, SEC23A and the soluble ER 
chaperone Protein Disulfide Isomerase [PDI]) (Figure 11A-C).  
The impaired delivery of PC1 to lysosomes in CRISPR Fam134b MEFs was rescued by 
reintroducing WT human FAM134B, but not a FAM134B protein lacking the (LIR) motif 
(FAM134Blir), in which interaction with LC3 is abolished [41] (Figure 11D). Taken 
together these data strongly suggest a primary role of FAM134B in mediating the delivery 
of ER resident PC molecules to lysosomes.  
 29 
 
 
Figure 11. FAM134B absence causes specific intracellular accumulation of PC1 and 
fails to increase accumulation of other ER resident proteins.  
(A) WT and CRISPR-Cas9 Fam134b knockout MEFs were treated as indicated, lysed and 
analysed by western blot. Bands were visualised with antibodies against PC1, LC3 and 
FAM134B. β-actin was used as a control. Western blots are representative of 4 independent 
experiments. (B) WT and KO MEFs for indicated genes were lysed at steady state and 
analysed by western blotting. Bands were visualised with antibodies against VAPA, 
SEC23A and PDI. α-tubulin or β-actin were used as controls. Western blots are 
representative of 3 independent experiments. (C) WT and CRISPR-Cas9 Fam134b MEFs 
were immunolabeled for PC1 (568, red), nuclei stained with Hoechst (blue) and analysed by 
scanning confocal microscopy, scale bar = 10 µm. (D) CRISPR-Cas9 Fam134b  knockout 
MEF mock transfected or transfected with wild type FAM134B-HA or FAM134Blir-HA. 
Cells were treated for 12h with 50 nM BafA1, immunolabeled for PC1 (568, red), LAMP1 
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(488, green) and HA (647, violet) and analysed by scanning confocal microscopy. Scale bar 
= 10 µm. Inset panels shows magnification of the boxed area. Bar graph shows quantification 
of LAMP1 vesicles positive for PC1, expressed as % of total lysosomes (mean +/- SEM), 
quantification of n=10 cells per treatment; 3 independent experiments. One-way ANOVA 
with Dunnett’s multiple comparisons test was performed *** P<0.0001. 
 
 
 
 
CALNEXIN is required for autophagy of procollagen 
FAM134B is not predicted to have an ER luminal domain, so is unlikely a direct interaction 
with PC molecules in the ER. We also hypothesized that the PC molecules destined for 
degradation need to be selectively recognized by ER quality control machinery in order to 
be subjected to FAM134B-mediated ER-phagy. Therefore, we investigated the involvement 
of ER chaperones in autophagy of PC. Taking advantage of a published list of putative PC1 
and FAM134B ER interactors [46, 69], we silenced different ER genes by RNAi. The 
silencing of the transmembrane chaperone CANX most effectively inhibited the delivery of 
PC1 to lysosomes in Saos2 cells treated with BafA1 (Figure 12A). Similar to what we 
observed in CRISPR Fam134b MEFs, Canx–/– MEFs showed an accumulation of 
intracellular PC1 but not of other ER-resident proteins (VAPA, SEC23A and PDI) (Figure 
12B-C).  When WT MEFs were treated with BafA1, the intracellular PC levels increased as 
consequence of defective lysosomal degradation. Conversely, in Canx–/– MEFs no further 
increase was observed in presence of BafA1, implying that no lysosomal accumulation can 
occur in the absence of Canx (Figure 12B). MEFs lacking Canx or Crt (Calreticulin) 
expression had an impaired PC1 delivery to lysosomes. Similarly, MEFs lacking ERp57, a 
protein disulfide isomerase that cooperates with CANX and CRT to ensure a proper folding 
of proteins [70], also showed a defective PC1 delivery to lysosomes (Figure 12D). The 
binding of CANX and CRT to target substrates occurs through the recognition of 
monoglucosylated oligosaccharide residues generated either by ER glucosidases I and II or 
by UDP-glucose:glycoprotein glucosyltransferase (UGT1) proteins [71, 72]. 
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Pharmacological inhibition of glucosidase activities with Castanospermine (CST) or 
deletion of Ugt1 in MEFs also inhibited PC1 delivery to lysosomes (Figure 12D). These 
data indicate that all the components of the CANX/CRT cycle are required to operate the PC 
folding quality control and to select the misfolded PC destined to autophagy.  
 
 
Figure 12. CANX is required for autophagic targeting of ER luminal PC1 and its 
deficiency fails to increase accumulation of other ER resident proteins. 
(A) Bar graph shows quantification of lysosomes (LAMP1+) containing PC1 expressed as 
% of lysosomes (mean +/- SEM) in Saos2 cells mock transfected or transfected with SiRNA 
against the indicated genes, treated with 100 nM BafA1 for 9h.  n=18 cells/treatment; 3 
independent experiments. One-way ANOVA (P<0.0001) with Dunnett’s multiple 
comparisons test performed, * P<0.05, *** P=0.0002. (B) WT and Canx–/– MEFs were left 
untreated or treated with BafA1 (10 μM) for 6 h, lysed and analysed by western blot with 
indicated antibodies. Filamin and β-actin were used as loading control. Dashed line indicates 
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that unnecessary lanes were removed. Western blot is representative of 3 independent 
experiments. (C) WT and KO MEFs for indicated genes were lysed at steady state and 
analysed by western blotting. Bands were visualised with antibodies against VAPA, 
SEC23A and PDI. α-tubulin or β-actin were used as controls. Western blots are 
representative of 3 independent experiments. (D) MEF cell lines knock-out or CRIPSR-Cas9 
for indicated genes were treated for 12h with 50 nM BafA1 fixed and immunolabeled for 
PC1 (568, red) and LAMP1 (488, green). CST was added where indicated. Scale bar = 10 
µm. Inset panels show magnification of the boxed area. Bar graph shows quantification of 
LAMP1 vesicles positive for PC1, expressed as % of total lysosomes (mean +/- SEM), n=8, 
8, 12, 8, 8, 8 cells respectively; 3 independent experiments. One-way ANOVA with 
Dunnett’s multiple comparisons test performed and P value adjusted for multiple 
comparisons. *** P<0.0001.  
 
 
Procollagens are the main substrates that accumulate in Fam134b–/– and Canx–/– cells 
Quantitative proteome analysis was performed using Mass Spectrometry (MS) label-free 
protein quantification approach in Canx–/– and Fam134b–/– MEFs versus wild-type MEFs. 
Canx–/– and Fam134b–/– samples were prepared and run in parallel to minimize the 
variability due to the MS calibration and sample preparation. We identified 95 upregulated 
and 142 downregulated proteins in Fam134b–/– MEFs. Specifically, both Col1a1 and Col1a2 
peptide chains were among the most significantly increased (–Log Student’s T-test p value: 
8.55 and 8.2, respectively for Col1a1 and Col1a2) (Figure 13A). Gene ontology analysis 
confirmed the accumulation of collagens in MEFs lacking FAM134B (Figure 13C). In 
Canx–/– cells, we identified 384 upregulated and 278 downregulated proteins. Col1a1 and 
Col1a2 peptides were identified as significantly increased also in Canx–/– MEFs (–Log 
Student’s T-test p value: 3.06 and 2.37, respectively for Col1a1 and Col1a2) (Figure 13B). 
Interestingly, only 17 identified peptides were commonly upregulated in both Fam134b–/– 
and Canx–/– MEFs. Among these, collagens (Col1a1, Col1a2, Col6a1, Col6a2, Col5a1) and 
collagen interacting proteins (Procollagen C-endopeptidase enhancer 1, 
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SPARC/Osteonectin) were the most represented categories (Figure 13D).  These data show 
that FAM134B and CANX are important regulators of PC proteostasis and that they might 
cooperate for the selective removal of misfolded procollagens in the ER.  
 
 
 
Figure 13. PCs are the main substrates of Fam134b–/– and Canx–/– cells. 
(A, B) Volcano plot comparing protein fold changes between WT versus Fam134b–/– (A) 
and  WT versus Canx–/– MEFs (B). Significantly regulated proteins are labelled in red (log2 
fold change > 1, –log10 p>1.3). Red dots with blue ring indicate collagen 1 peptides. Graphs 
represent statistics from three separate experiments for each genotype. (C) Scatter plot for 
1D annotation enrichment analysis of significantly up-regulated peptides in the Fam134b–/– 
MEFs proteome. (D) Venn diagrams represent the number of identified peptides 
significantly enriched in Fam134b–/– (left) and Canx–/– MEFs (right). List of peptides 
upregulated in both Fam134b–/– and Canx–/– MEFs. 
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A CANX-FAM134B ER-phagy complex acts as PC autophagy receptor   
Mass spectrometry analysis identified CANX as a putative FAM134B interactor [46]. We 
confirmed this interaction by co-immunoprecipitation experiments. CANX has a N-terminal 
ER luminal domain, a single transmembrane helix and a short acidic cytoplasmic tail.  
FAM134B instead is composed of an N-terminal cytosolic domain, a reticulon homology 
domain (containing alpha helices and a cytosolic loop) and a C-Terminal cytosolic domain 
(Figure 14A). Thus, CANX and FAM134B could potentially interact either in the cytosol 
or in the ER membrane. We found that the interaction between CANX and FAM134B is lost 
when co-IP experiments were performed using a mutant version of FAM134B that lacked 
the intramembrane part of the reticulon homology domain, suggesting that FAM134B 
interacts with CANX in the ER membrane (Figure 14B). Notably, the FAM134Blir mutant 
still interacts with CANX in co-IP experiments (Figure 14B-C).    
FAM134B-CANX interaction was not modulated by PCs, since it occurs in HeLa (Kyoto) 
cells that do not express significant amounts of collagens [73] (Figure 14D). Functionally, 
CANX is not required for FAM134B-mediated ER-phagy, as FAM134B is recruited to LC3-
positive vesicles with the same efficiency in both Canx–/– and WT MEFs (Figure 14E-F).  
We postulated that FAM134B interacts with misfolded PC molecules via CANX.  To test 
this hypothesis, we generated a human osteosarcoma cell line (U2OS) expressing PC2 
molecules tagged with HALO at the N-terminus. HA-resin mediated pull down experiments 
using HA tagged FAM134B or FAM134Blir showed that both HALO-PC2 and CANX 
interact with FAM134B, irrespective of whether it contained the LIR domain or not (Figure 
14C). Conversely co-precipitation of LC3II was dependent on a functional LIR motif in 
FAM134B (Figure 14C), consistent with previous results [41]. Castanospermine treatment 
diminished the level of HALO-PC2 co-precipitated by FAM134B-HA (Figure 14C) without 
perturbing the co-precipitation of CANX and LC3II. Taken together these data suggest a 
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model by which the interaction of PC with FAM134B is mediated by CANX and that the 
selective degradation of PC mediated by FAM134B is dependent on PC binding to CANX.  
 
 
Figure 14. CANX and FAM134B interact and deliver PC1 to autophagosomes. This 
interaction is not modulated by PC.  
(A) Schematic representation of FAM134B WT, lir mutant and delta reticulon constructs. 
(B, C) (B) U2OS cells were transfected with empty vector control (pcDNA3), FAM134B-
HA WT or mutant constructs as indicated. (C) U2OS cells transfected with HALO-PC2, and 
mock transfected or transfected with FAM134B-HA or FAM134Blir-HA constructs, treated 
with 100 nM BafA1 for 6h and CST where indicated; Complexes were immune-isolated 
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with HA-magnetic beads, separated by western blot and visualised with antibodies against 
HALO, CANX, FAM134B, LC3 and β-ACTIN. 5% of the input is shown. Western blots are 
representative of 3 independent experiments. Dashed line indicates that unnecessary lanes 
were removed. (D) HeLa (Kyoto) cells were transfected with empty vector control, 
FAM134B-HA WT or mutant constructs as indicated. Complexes were immune-isolated 
with HA-magnetic beads, separated by western blot and visualised with antibodies against 
CANX, FAM134B and β-ACTIN. 5% of the input is shown. Western blots are representative 
of 3 independent experiments. (E) Representative immunofluorescence of WT and Canx–/– 
MEFs that were transiently transfected with RFP-LC3 (red) and GFP-FAM134B (green). 
Scale bar = 10 m. (F) Quantification of AVs positive for RFP-LC3 (red) containing 
FAM134B (green) expressed as % of total LC3, FAM134B and FAM134B+LC3 per cells 
(mean +/- SEM). n= 12 cells counted per condition; 3 independent experiments. 
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Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38 
 
The FAM134B-CANX complex as a clearing mechanism for PC 
In this work we have shown the mechanism by which autophagy selectively recognizes PC 
molecules destined for degradation in the ER. We have shown that the ER transmembrane 
chaperone CANX interacts with FAM134B and LC3, forming a novel ER-phagy complex 
with specific protein targeting capabilities. This complex is responsible for a specific ER-
clearance mechanism of PCs, and links a non-native large protein within the ER lumen to 
the cytosolic autophagy machinery (Figure 15). 
 
 
Figure 15. Proposed model of collagen recognition by autophagy.  
After synthesis, PC chains are subjected to the quality control operated by the CANX/CRT 
chaperone system. Properly folded PCs associate with HSP47 and they are then secreted. On 
the contrary, the misfolded fraction is sequestered by CANX-FAM143B complex and it is 
delivered to the lysosomes through ER-phagy for degradation.  
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Firstly, we have found that the all the autophagy machinery is important in PC delivery to 
the lysosomal system. In fact, we have identified that silencing genes belonging to 
functionally different complexes involved in autophagosome biogenesis inhibited lysosomal 
delivery of PCs. Secondly, we have identified the importance of the ER-phagy receptor 
FAM134B in mediating PC delivery to the lysosomes. FAM134B was recently identified as 
a receptor that mediates turnover of ER portions via autophagy [41]. These data suggest that 
FAM134B-dependent ER-phagy also functions as an ER quality control pathway for PCs. 
In fact, quantitative proteomic analysis in Fam134b–/– MEFs suggests that PCs are the main 
clients of FAM134B-mediated ER-phagy. Lastly, we have shown that the ER chaperone 
CANX represents an important player in PC disposal via ER-phagy. CANX is a molecular 
chaperone that assists the folding of monoglucosylated glycoprotein in the ER.  CANX 
forms transient complexes with unfolded ER proteins until they either become folded or are 
degraded [74]. Our data demonstrated that the genetic or pharmacological inhibition of ER 
enzymes that mediate the binding of substrates to CANX impaired the PC delivery to the 
lysosomes. This suggests that the N-glycans-mediated recognition of PC by CANX (and 
CRT) is a prerequisite for PC targeting to autophagosomes. Consistently co- 
immunoprecipitation experiments demonstrate that PC2 binding to FAM134B complex 
depends on CANX substrate affinity, since it can be reduced by CST treatment. Finally, we 
have also provided biochemical evidence indicating that FAM134B interacts with CANX 
via the transmembrane reticulon homology domain. The reticulon homology domain 
generates membrane curvature and remodelling by increasing the area of the cytoplasmic 
leaflet [75]. The observation that CANX-FAM134B binding is rather stable and not 
modulated by PCs suggests that the binding of PC to CANX might induce a conformational 
change of the FAM134B reticulon homology domain that increases ER membrane curvature, 
favouring vesicle formation. Indeed, CLEM analysis confirmed the presence of both PC 
molecules and CANX within a small vesicle contained within a large autophagosome, 
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supporting the model by which portions of the ER containing both CANX and PC are 
sequestered into autophagosomes. These data overall show the importance of FAM134B-
mediated ER-phagy in maintaining cellular proteostasis and degradation for procollagen 
molecules.  
 
The FAM134B-CANX complex as a clearing mechanism for additional proteins  
FAM134B has recently emerged also in the lysosomal degradation of a mutant form of 
alpha1-antitrypsin Z (ATZ), together in complex with CANX [34]. The pathway identified 
for the proteasome-resistant ATZ was named ER-to-lysosome associated degradation 
(ERLAD). In ERLAD, the protein aggregates of ATZ are first segregated in ER subdomains, 
then enclosed in transport vesicles that eventually fuse with lysosomes for degradation 
(Figure 16). It shows substantial differences compared to the quality control autophagy of 
endogenous PC. Firstly, the delivery of PC molecules to lysosomes fully relies on 
autophagosome formation and on components of the autophagosome biogenesis machinery. 
Conversely, many of them (e.g. ULK1/2, ATG9 and ATG13) are dispensable for ERLAD, 
suggesting that the CANX-FAM134B complex can mediate ER cargo clearance though 
different vesicular pathways. Secondly, both in quality control autophagy of PC and 
ERLAD, the ER chaperone CANX delivers the misfolded cargo in ER subdomains to be 
cleared from cells on stable interactions with FAM134B. However, other components of the 
CANX chaperone system (i.e., CRT, UGT1 and ERp57) cycle are required in quality control 
autophagy of PC, but are dispensable for ERLAD. These results highlight the complexity of 
quality control pathways operating in mammalian cells to surveil the ER lumen and prevent 
accumulation of misfolded proteins in the ER. All in all, FAM134B has emerged to have a 
crucial role in controlling cellular proteostasis operating in different ER quality control 
pathways and involving many ER clients, including PC and ATZ.  
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Figure 16. The possible routes of FAM134B-mediated vesicular transport for cargo 
degradation.  
The ER-resident receptor FAM134B transits from the ER via different routes: via ER-phagy 
(for the selective degradation of procollagen) and via ER-to-lysosome associated 
degradation (ERLAD, for the selective degradation of alpha1-antitrypsin Z). In ER-phagy, 
the PC delivery to the lysosomes requires autophagosomes, LC3 positive (in blue). In 
ERLAD, the protein aggregates of ATZ are first segregated in ER subdomains, then enclosed 
in ER single-membrane transport vesicles that eventually fuse with lysosomal degradative 
organelle, not requiring autophagosome formation. Abbreviations: ER, endoplasmic 
reticulum; PC, procollagen; AV, autophagic vesicle; CANX, Calnexin; ATZ, alpha1-
antitrypsin Z; LIR domain, LC3 interacting region. 
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Alternative pathways of degradation for PC molecules 
Procollagen molecules are degraded via at least three different collagen quality control 
pathways that operate during the different steps of procollagen production in the ER (Figure 
17). The first mechanism of PC degradation to be described is operated by ERAD, for single 
procollagen chains that are not yet trimerized [21]. The second, herein described operated 
by ER-phagy, during trimerization and mediated by the Calnexin and related chaperones. 
However, a third pathway is emerged for PC degradation, operated by microautophagy at 
level of ER-exits sites prior secretion [33]. PCs destined to secretion leave the ER through 
sub-regions called ER exit sites (ERESs) via coat protein complex II (COPII)-coated vesicles 
[59, 76]. The ERESs represent very specialized ER zones for the transport of cargo proteins 
from the ER to the Golgi apparatus and are highly regulated [76]. Misfolded procollagens 
have been shown to accumulate at the ER exit sites, that are then engulfed by lysosomes 
through a microautophagy-like mechanisms, not involving conventional, double-membrane 
autophagosomes [33]. Of note, this described process for PC degradation may ensue at an 
earlier stage of PC trafficking, occurring at the ERESs, so that overall only properly folded 
PCs enter the secretory pathway.  
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Figure 17. PC quality control pathways at the ER.  
Distinct PC quality control exists operating during the different steps of PC production in 
the ER: ER-associated degradation, for degradation of single procollagen chains. ER-
phagy, during trimerization and mediated by the FAM134B-Calnexin complex. 
Microautophagy at level of ER-exit sites prior secretion. Continuous lines represent folded 
PC molecules at the ER during different steps, from biosynthesis to secretion. Dashed lines 
represent misfolded collagen delivered to degradative pathways. Abbreviations: PC, 
procollagen; N, N-terminal domain; C, C-terminal domain; ERES, ER-exit sites; CANX, 
Calnexin; Lys, lysosome; AV, autophagic vesicle; COPII, COPII vesicles. 
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Concluding Remarks 
The FAM134B-mediated ER-phagy plays different cellular functions, from maintaining ER 
homeostasis and size to the selective removal of specific cargoes from the ER. The 
impairment of ER-phagy leads to a lack of ER homeostasis and protein accumulation, 
representing a primary pathogenic cause for a number of human diseases. Therefore, the 
identification of the underlying mechanisms related to the ER-phagy is fundamental to 
develop potential therapeutic targets to tackle potentially this pathway in human disorders, 
such as conformational diseases. 
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Materials and Methods 
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Cell culture, transfections, siRNA and plasmids 
Cell culture: Mouse Embryonic Fibroblasts (MEFs) and Swarm Rat Chondrosarcoma (RCS) 
cell lines were cultured in DMEM with 10% FBS and 1% penicillin/streptomycin at 37°C in 
5% CO2. Human bone Osteosarcoma (Saos2 and U2OS) cells were purchased from ATCC 
and cultured in McCoys medium with 15% (Saos2) or 10% (U2OS) FBS and 1% 
penicillin/streptomycin at 37°C in 5% CO2. For collagen experiments, medium was 
supplemented with 50 μg/ml ascorbic acid. Wild-type, Atg7–/–, MEFs were gifts from M. 
Komatsu and N. Mizushima. Atg16–/– MEFs were from T. Saitoh. Fip200–/– MEFs were from 
J.-L. Guan. The generation of the Sec62 CRISPR-Cas9 knockout MEF cell line was 
previously described [45]. Canx–/– MEF cell lines were previously described [77]. Fam134b 
CRISPR-Cas9 MEF cell line was generated in [34].  Fam134b–/– MEF cell line was generated 
in [41]. Crt–/–, Erp57–/– and Ugt1–/– were previously described [78-80].   
Saos2 IDUA CRISPR-Cas9 cell line: for construction of the guideRNA-Cas9 plasmid, 
pSpCas9(BB)-2A-Puro plasmid (PX459) (Plasmid #62988) was obtained from Addgene. To 
clone the guide sequence into the sgRNA scaffold, two annealed oligonucleotides (5’-
CACCGCAGCTCAACCTCGCCTATG-3’, 5’- AAACCATAGGCGAGGTTGAGCTGC-
3’) were inserted into the pSpCas9(BB)-2A-Puro plasmid using BbsI restriction site. Saos2 
cells were transfected with the plasmid using Lipofectamine LTX and Plus Reagent 
(Invitrogen, Thermo Fisher Scientific) following a reverse transfection protocol. Two days 
after transfection, the medium was supplemented with 1 μg/ml puromycin. Puromycin-
resistant clones were isolated and gene KO was verified by sequencing. CRISPR IDUA and 
WT Saos2 cells were kept in medium containing 1 mg/ml dermatan sulphate (Sigma-
Aldrich) for 48 hours before any experiment was performed.  
Transfection: Cells were reverse transfected using Lipofectamine LTX and PLUS reagent 
(Invitrogen) according to manufacturer’s instructions. For siRNA experiments, siGENOME 
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SMARTpool siRNAs (Dharmacon Thermo Scientific) were transfected to a final 
concentration of 100 nM and cells harvested 72h after transfection.  
Plasmids: GFP–LC3 was from Dr. Yoshimori. GFP-DFCP1 was from Dr. Tooze. 
FAM134Blir-HA and FAM134BReticulon-HA  expression plasmids were from Prof. Ivan 
Dikic. HALO-PC2 plasmid was generated as follows: pLT007, a vector for CMV promoter-
driven expression of N-terminally Halo-tagged Col2a1 was created by replacing the 
mCherry tag with the Halo tag in the mCHERRY-C2-COL2A1 plasmid [81]. Standard 
techniques were used for construction, transformation and purification of plasmids. 
FAM134B-GFP was previously described [41]. Site directed mutagenesis plasmids: R789C 
and G1152D mutations were created using the Agilent Quikchange XL Site-Directed 
mutagenesis kit using the mCherry-PC2 backbone.  
Primer sequences were designed with PrimerX online software and were as follows: R789C 
forward: 5' CGGTCTGCCTGGGCAATGTGGTGAGAGAGGATTC 3' and reverse: 5' 
GAATCCTCTCT CACCACATTGCCCAGGCAGACCG 3'; G1152D forward: 
5'GGTCCTTCTGGAGACCAAGATGCTTCTGGTCCTGCTGG 3' and reverse: 5' 
CCAGCAGGACCAGAAGCATCTTGG TCTCCAGAAGGACC 3'. 
 
Immunofluorescence 
Cells were seeded on coverslips at least 24h before treatment and fixed for 10 min in 4% 
PFA, or for the detection of endogenous LC3, fixed for 10 min in ice-cold methanol. Cells 
were blocked and permeabilized for 30 min in blocking buffer (0.05% (w/v) saponin, 0.5% 
(w/v) BSA, 50 mM NH4Cl and 0.02% NaN3 in PBS, pH 7.2-7.4). For LAMP1 
immunolabeling, 15mM glycine was added to blocking buffer. Cells were incubated for 1h 
with the following primary antibodies: COLLAGEN I (SP1.D8, Hybridoma Bank), 
COLLAGEN II (II-II6B3; Hybridoma Bank), LAMP1 (Abcam, ab24170) or LAMP1 
(Hybridoma Bank, 1D4B), CANX (Enzo Life Sciences ADI-SPA-860-D), LC3 (NB100-
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2220; Novus Biologicals), HSP47 (Abcam, ab77609); HA (Sigma, H6908), washed 3 times 
in PBS; incubated for 45 min with secondary antibody (Alexa Fluor–labelled goat anti-rat 
A11077, goat anti-guinea pig A11073, goat anti-rabbit A11011/A11008, and goat anti-
mouse A11001, A11004; Life Technologies, Thermo Fisher Scientific); washed 3 times in 
PBS; incubated for 20 minutes with 1 μg/ml Hoechst 33342, and finally mounted in Mowiol 
(Sigma-Aldrich) or Vectashield (Vector Laboratories) supplemented with 40,6-diamidino-
2-phenylindole (DAPI) .  
 
Medaka stocks 
Samples of the Cab strain of wild-type medaka fish were kept and staged as described 
previously [82, 83]. All studies on fish were conducted in strict accordance with the 
institutional guidelines for animal research and approved by the Italian Ministry of Health; 
Department of Public Health, Animal Health, Nutrition and Food Safety in accordance to 
the law on animal experimentation (article 7; D.L. 116/92). Furthermore, all animal 
treatments were reviewed and approved in advance by the Ethics Committee at the TIGEM 
Institute [Pozzuoli (NA), Italy]. 
 
Immunofluorescence analysis in Medaka fish embryos   
The animals were subjected to anaesthesia before fixation at stage 40 by two hours of 
incubation in Methanol 100% at room temperature (RT). Samples were rinse three times 
with PTw 1X (1xPBS, 0.1% Tween, pH 7.3) and then incubated overnight in 15% 
sucrose/PTW1X at 4°C, and then again incubated overnight in 30% sucrose/PTW1X at 4°C. 
Cryosections of the larvae were processed for immunostaining. Specifically, cryosections 
were rehydrated in PBS1X for 30 minutes, washed in PBS-0.1% Triton X-100 and treated 
with antigen retrieval solution [proteinase K 20mg/ml (Sigma Aldrich, Germany) dissolved 
in 10 mM TRIS pH 8.0, 1mM EDTA (TE)] for 15 minutes at 37°C. Cryosections were then 
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permeabilized with 0.5% Triton X-100 in PBS1X for 20 minutes at RT, rinsed in PBS 0.1% 
Triton X-100 and moved to blocking solution [2% BSA, 2% serum, 2% DMSO in PBS-0.1% 
Triton X-100] for 30 minutes at RT. Cryosections were incubated with rabbit anti-Collagen 
Type I (1:400) and mouse anti-LC3B (Nanotools, 1:100) antibodies over night at 4°C. 
Cryosections were washed with PBS-0.1% Triton X-100 and incubated with secondary 
antibodies, Alexa-594 anti-rabbit IgG (1:500), Alexa-488 anti-mouse IgG (1:500) (Thermo 
Fisher) for one hour at RT. Nuclei were stained with DAPI (1:500).  
 
Chemicals and cell treatments  
L-Ascorbic acid (Sigma-Aldrich) was made fresh and used at a final concentration of 50 
µg/ml from the beginning of each experimental procedure. Bafilomycin A1 (BafA1) (Sigma-
Aldrich) was used at a final concentration of 100 nM, and compared to DMSO (Sigma-
Aldrich) as vehicle for 6h (RCS) or 9h (Saos2/U2OS). MEFs were treated with 50nM 
Bafilomycin for 12h or 100nM for 6h. For Bafilomycin washout experiments, BafA1 was 
added 100nM for 4 h, followed by 4 h washout adding medium without BafA1. 
Castanospermine (CST) (Sigma-Aldrich) was used at a final concentration of 1 mM. CST 
was added 2h before BafA1 and ascorbic acid treatment. Tat-BECLIN1 (D17, Millipore) 
was used at 5μM in acidified media for 4 h, then replaced with fresh media for 2 h before 
harvesting the cells. SAR405 (Selleckchem) was used at a concentration of 10 μM for 2 
hours preceding and throughout BafA1 treatment. HALO-tag, far red (ex. 650 nm, em. 
668 nm) SiR HaloTag ligand (Promega), available through custom order, incubated in media 
at 2 mM for 3 h. 0.5 µM TMR (Promega) was added to the media 2h pre-fixation for 
lysosome visualisation, or for pulse chase, 20 min at 1 µM, followed by p5030 (Promega). 
Rutin (Acros Organics) was used at 10 µg/mL for the duration of live cell imaging. 
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Confocal Microscopy  
Scanning laser confocal experiments were acquired using a Zeiss LSM 800 confocal 
microscope equipped with a 63 × 1.4 numerical aperture oil objective. Airyscan microscopy 
was performed using a Zeiss LSM 880 confocal microscope, equipped with Plan-
Apochromat 63x/1.4 numerical aperture oil objective and pixel size of 8.7nm. Images were 
subjected to post-acquisition airyscan processing. Image acquisition and processing was 
performed with Zen Blue software and colocalization analysis and image presentation was 
performed using ImageJ FIJI software. 
 
Live Cell Imaging 
U2OS cells were transiently transfected with mCherry-PC2 and RDEL-HALO plus GFP-
LC3. Cells were incubated on a Tokai Hit stage top incubator heated stage in 5% CO2 at 40 
°C in the presence of far red HALO ligand for 3 h. Immediately prior to imaging, medium 
was supplemented with ascorbic acid and rutin (routinely used to decrease photobleaching). 
Imaging was initiated at temperature switch to 32 °C. Frames were acquired at 1 s intervals. 
Imaging was performed on a Nikon Inverted Spinning Disk confocal with sCMOS Prime95B 
camera (Photometrics) with pixel size of 11 μm, using a 100x CFI Plan Apo oil objective 
with 1.4 NA.  Image acquisition was performed with Metamorph 7.7.6 software (Molecular 
Devices, France) and processing in ImageJ FIJI software.  
 
Correlative light-electron microscopy (CLEM) and Tomography 
Saos2 cells were grown on gridded MatTek glass bottomed dishes (MatTek Corporation) 
transfected with GFP-LC3 and fixed with 0.05% glutaraldehyde in 4% paraformaldehyde 
(PFA) and 0.1M Hepes buffer for 10 min, washed once in 4% PFA, then incubated in fresh 
4% paraformaldehyde in 0.1M Hepes buffer for 30 min. Subsequently, cells were incubated 
for 30 min in blocking buffer and immunolabeled for collagen I (SP1.D8) and CANX (ADI-
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SPA-860-D Enzo Life Sciences), visualized with Alexa-Fluor546 fluoro-nanogold Fab’ 
conjugate (Nanoprobes) and Alexa-Fluor647 Rabbit Ab respectively. Nanogold was 
enlarged using gold enhancement kit (Nanoprobes) according to manufacturer’s instructions. 
Samples were then postfixed with 1.5% potassium ferricyanide, 1% OsO4 in 0.1 M 
cacodylate buffer for 1 hour on ice and enbloc stained overnight with 1% uranyl acetate. 
Samples were dehydrated in ethanol, and embedded in Epoxy resin (SIGMA). After baking 
for 48h at 60°C, the resin was released from the glass coverslip by temperature shock in 
liquid nitrogen. Serial sections (70–90 nm) were collected on carbon-coated formvar slot 
grids and imaged with a Zeiss LEO 512 electron microscope. Images were acquired with a 
2k×2k bottom-mounted slow-scan Proscan camera controlled by EsivisionPro 3.2 software. 
For electron tomography tilted series were acquired with a 200kV Tecnai G2 20 electron 
microscope (FEI, Eindhoven) at a magnification of 11.5k, resulting in pixel size of 1.95nm. 
Single, tilted image series (±60° according to a Saxton scheme with the initial tilt step of 2°) 
were acquired using Xplorer3D (FEI) with an Eagle 2,048×2,048 CCD camera (FEI). Tilted 
series alignment and tomographic reconstructions were done with the IMOD software 
package. Image segmentation was done by MIB software (BW thresholding) and visualized 
using IMOD. 
 
Transmission Electron Microscopy 
Cells were fixed in 1% glutaraldehyde in 0.2 M HEPES buffer and then post-fixed in uranyl 
acetate and in OsO4. After dehydration through a graded series of ethanol, samples were 
cleared in propylene oxide, embedded in Epoxy resin (Epon 812) and polymerized at 60°C 
for 72h. From each sample, thin sections were cut with a Leica EM UC6 ultramicrotome and 
images were acquired using a FEI Tecnai −12 (FEI) electron microscope equipped with 
Veletta CCD camera for digital image acquisition. 
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Immunoprecipitation experiments 
HA-tag precipitation: U2OS cells were transiently transfected with plasmids encoding 
HALO-PC2 and FAM134B-HA. On the day of experiment, plates were treated with 1mM 
CST where indicated for 2h, then all plates treated with 100nM BafA1 and 50 µg/ml ascorbic 
acid for 4h.  Cells were detached with Tripsin-EDTA and centrifuged. The cell pellets were 
washed three times with ice-cold PBS, then resuspended in 1mL MCLB lysis buffer (1% 
NP-40, 150mM NaCl, 50mM Tris HCl pH8). The cell suspension was lysed by passing it 
through a 24G needle for 10-15 times. The lysates were incubated on ice for 20 minutes with 
gentle swirling and centrifuged at 14000rpm to pellet nuclei and cell debris. The supernatants 
were collected and subjected to protein quantification using BCA protein assay kit (Pierce 
Chemical). 1mg of each lysate was then precipitated using Pierce anti-HA magnetic beads 
(Thermo Fisher Scientific) and rotated at 4°C overnight. The precipitated proteins were 
washed three times with MCLB lysis buffer (1% NP-40, 150mM NaCl, 50mM Tris HCl 
pH8) and two times with the same lysis buffer, detergent free. The protein complexes were 
resuspended in 1v/v 2X Laemli Sample buffer and analysed by SDS-PAGE in a 7-14% 
gradient gel.  
HeLa (Kyoto) cells and U2OS cells were transiently transfected with empty vector control, 
FAM134B-HA WT or mutant constructs. On the day of the experiment cells were detached 
with Tripsin-EDTA and centrifuged.  Immunoprecipitation experiments were performed in 
the same conditions and analysed by SDS-PAGE in a 4–15% Mini-PROTEAN® TGX™ 
Precast Protein gel.  
 
Western blot analysis 
Cells were washed twice with PBS and then scraped in RIPA lysis buffer (20 mM Tris [pH 
8.0], 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate) in the presence of 
PhosSTOP and EDTA-free protease inhibitor tablets (Roche). Cell lysates were incubated 
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on ice for 30 minutes, then the soluble fraction was isolated by centrifugation at 16,000 g for 
20 minutes at 4°C. The total protein concentration in cellular extracts was measured by BCA 
protein assay kit (Pierce Chemical). Protein extracts, separated by SDS-PAGE and 
transferred onto membranes, were probed with antibodies against COLLAGEN I (Abcam, 
ab138492 for human cells; Abcam, ab21286 for mouse cells), LAMP1 (Abcam, ab24170), 
LC3B (NB100-2220; Novus Biologicals), CANX (Enzo Life Sciences ADI-SPA-860-D), 
HALO (Promega G928A) FAM134B (Sigma, HPA012077), SQSTM1/p62 (Abnova, 
H00008878-M01), SEC23A (PAI-069A; Thermo Fisher Scientific), VAP-A (15275-1-AP, 
Proteintech), PDI (Enzo Life Sciences ADI-SPA-891-F), FILAMIN (Abcam, ab76289), 
TUBULIN (T5168, Sigma-Aldrich) and β-ACTIN (Novus Biologicals NB600-501), probed 
with horseradish peroxidase (HRP)-conjugated goat anti-mouse or anti-rabbit IgG antibody 
(1:2,000, Vector Laboratories) (8125, 8114; Cell Signaling Technology) and visualized with 
the Super Signal West Dura substrate (Thermo Fisher Scientific), according to the 
manufacturer’s protocol.  
 
Mass spectrometry 
Wild-type, Fam134b and Canx knockout MEFs were grown in DMEM media supplemented 
with 10% FBS. Cells were lysate in SDS-lysis buffer (4% SDS in 0.1M Tris/HCl pH 7.6). 
Protein concentration was measured using BCA Kit (Pearce) and 50g of cells lysate was 
precipitated with ice-cold acetone and re-suspended in 30l of GnHCl buffer (6M guanidine 
hydrochloride, 50mM Tris pH 8.5, 5mM TCEP, 20mM chloro-iodoacetamide). For label-
free quantification-based proteome analysis of whole cell lysates, proteins were in-solution 
digested with the endopeptidase sequencing-grade Lys-C (1:100 ratio) for 3h at 37°C and 
subsequently with Trypsin (1:100 ratio) overnight 37°C. Digestion was blocked with TFA 
1% final concentration. Collected peptide mixtures were concentrated and desalted using the 
Stop and Go Extraction (STAGE) technique [84].  
 54 
 
Instruments for LC-MS/MS analysis consisted of a NanoLC 1200 coupled via a nano-
electrospray ionization source to the quadrupole-based Q Exactive HF benchtop mass 
spectrometer (Thermo Scientific). Peptide separation was carried out according to their 
hydrophobicity on an in-house packed 20cm column with 1.9mm C18 beads (Dr Maisch 
GmbH) using a binary buffer system consisting of solution A: 0.1% formic acid (0.5% 
formic acid) and B: 80% acetonitrile, 0.1% formic acid (80% acetonitrile, 0.5% formic acid). 
2 hr gradients were used for each sample. Linear gradients from 5–38% B were applied with 
a following increase to 95% B at 400nl/min and a re-equilibration to 5% B. Q Exactive HF 
settings: MS spectra were acquired using 3E6 as an AGC target, a maximal injection time of 
20ms and a 60,000 resolution at 200m/z. The mass spectrometer operated in a data dependent 
mode with subsequent acquisition of higher-energy collisional dissociation (HCD) 
fragmentation MS/MS spectra of the 15 most intense peaks. Resolution for MS/MS spectra 
was set to 30,000 at 200m/z, AGC target to 1E5, max injection time to 25ms and the isolation 
window to 1.6 Th.  
 
Statistics 
Statistics were performed in Graphpad PRISM software. A two-tailed, paired and unpaired 
Student’s T test were performed when comparing the same cell population with two different 
treatments or cells with different genotypes, respectively. One-way ANOVA and Dunnett’s 
post-hoc test were performed when comparing more than two groups relative to a single 
factor (treatment). A P value of 0.05 or less was considered statistically significant. 
For mass spectrometry analysis, the raw files were processed using MaxQuant software [85]. 
Parameters were set to default values. Statistical analysis, T-test and GO annotation 
enrichment were performed using Perseus software [86]. Data are representative of three 
independent mass spectrometry analyses for each genotype.    
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Introduction 
Although the role of ER-phagy in the regulation of ER size and cellular proteostasis has been 
well characterized, the upstream signaling pathways regulating ER-phagy in response to 
cellular needs are still largely unknown.  
Of note, chondrocytes reside in an avascular zone with scarcity of nutrients, being the growth 
plate. During endochondral ossification, these cells are highly secretory synthesizing 
extracellular matrix components, including collagens and proteoglycans [87]. Therefore, 
their activity must rely on efficient ER functions. As previously shown, the inhibition of 
autophagy in chondrocytes was associated to ER dysfunction suggesting that in these cells 
autophagy is necessary to maintain ER homeostasis, particularly during periods of high 
demand of protein secretion [61]. Moreover, our group has previously demonstrated that 
fibroblast growth factor (FGF) signaling is a potent activator of autophagy in chondrocytes 
[61]. All the above observations have led us to investigate whether FGF triggers a signaling 
cascade that culminates with the induction of ER-phagy. 
Specifically, it has been found that the nutrient responsive transcription factors TFEB and 
TFE3 - master regulators of lysosomal biogenesis and autophagy [88]- control ER-phagy by 
inducing the expression of lysosomal genes, involved in lysosomal biogenesis, and the ER-
phagy receptor FAM134B. The TFEB/TFE3-FAM134B axis promotes in turn ER-phagy 
activation upon prolonged starvation. In addition, this pathway has been shown to be 
activated in chondrocytes by FGF signaling, a critical regulator of chondrocyte 
differentiation (Figure 18).  
In this project, I have characterized how the FGF signaling activates the TFEB/TFE3 axis. 
Specifically, my work has led to identify that the FGF signaling induces a JNK-dependent 
proteasomal degradation of the insulin receptor substrate 1 (IRS1), which inhibits the 
insulin-PI3K-PKB/Akt-mTORC1 pathway and promotes TFEB/TFE3 nuclear translocation. 
In collaboration with the Medaka Facility, I have characterized the effect of FAM134B 
 57 
 
knock-down in Medaka embryos. Specifically, the lack of FAM134B impairs cartilage 
growth and mineralization in medaka fish. The model of the present project is shown in 
Figure 18 and the above data are further elucidated in the next sections.  
 
 
Figure 18. Representative model of induced ER-phagy in chondrocytes.  
FGF18, through FGFR3 and FGFR4 receptors, induces JNK-dependent phosphorylation and 
proteasomal degradation of IRS1 protein, which in turn inhibits the PI3K pathway and 
promotes TFEB/TFE3 nuclear translocation. In the nucleus, the active transcription factors 
co-induce the expression of lysosomal, autophagy genes and the ER-phagy receptor 
Fam134b. Concomitantly, nutrient starvation also promotes activation of TFEB/TFE3 
factors and enhances ER-phagy in chondrocytes. 
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Results 
FGF signaling activates TFEB/TFE3 through the insulin/PI3K signaling pathway 
inhibition 
TFEB and TFE3 activity is negatively regulated by phosphorylation on specific serine 
residues by nutrient and growth factor responsive kinases [89], such as mTORC1 and AKT. 
When phosphorylated, TFEB and TFE3 nuclear translocation is inhibited, hence they are 
inactive; on the contrary, the inhibition of these kinases, such as during starvation, promote 
TFEB and TFE3 dephosphorylation, nuclear translocation and activation of target genes 
[89]. To characterize the mechanism by which FGF signaling activated TFEB/TFE3 in 
chondrocytes we performed phospho-proteomics analysis that allowed us to quantify the 
dynamic response of approximately 20,000 phospho-sites upon FGF stimulation. We 
observed that insulin and PI3K-signaling scored as the most significantly inhibited upon 
FGF18 stimulation in chondrocytes. By mapping phospho-proteome and proteome profiles 
on a literature-curated insulin/IGF signaling network, we identified IRS1, the adaptor protein 
that transmits signals from the insulin/IGF receptors [90], as the most down-regulated 
protein by FGF18 treatment in chondrocytes (Figure 19).  
Figure 19. FGF signaling inhibits the insulin/PI3K signaling through down-regulation 
of IRS1. 
(Left) MS-phospho-proteomics analysis of RCS chondrocytes with indicated genotypes 
treated with vehicle (5% ABS) and FGF18 (50 ng/mL) for 12 hours, showing biological 
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processes regulated by FGF signaling (in blue: upregulated, in green: down-regulated). N=4 
biological replicates were analyzed. FDR<0.05.  
(Right) Proteomic signaling network modulated by FGF18 in chondrocytes. Red=activating 
phosphorylation; blue= inhibitory phosphorylation. Cubes dimensions are relative to level 
of protein regulation. 
 
 
Consistently, western blot analysis demonstrated that the activities of AKT and mTORC1 
kinases, downstream of the PI3K signaling, were strongly reduced following FGF18 
treatment (Figure 20). IRS1 down-regulation upon FGF stimulation was the consequence of 
its enhanced degradation, since it was prevented by treatment of RCS with the proteasome 
inhibitor MG132. The proteasomal degradation of IRS1 is triggered by phosphorylation 
mediated by different kinases, such as JNK1/2, mTORC1 or S6K21 [90]. FGF18 induced 
JNK1/2 activity, as demonstrated by phosphorylation of c-JUN, and pharmacological 
inhibition of JNK1/2 kinases blocked IRS1 degradation in FGF18 treated chondrocytes. 
Notably, IRS1 overexpression as well as JNK1/2 inhibition rescued mTORC1 and AKT 
signaling inhibition (Figure 20). mTORC1 and AKT phosphorylate TFEB and inhibit its 
nuclear translocation, thus we tested whether JNK-mediated IRS1 degradation induced 
TFEB and TFE3 nuclear translocation. Consistent with this hypothesis, TFEB/TFE3 
dephosphorylation and nuclear translocation following FGF18 stimulation were inhibited in 
chondrocytes overexpressing IRS1, treated with JNK1-inhibitor (Figure 20 and Figure 21). 
Collectively, these data suggest that FGF18 induces TFEB and TFE3- mediated lysosome 
biogenesis and ER-phagy via JNK-mediated IRS1 degradation and PI3K signaling 
inhibition.  
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Figure 20. FGF signaling activates TFEB/TFE3 through the insulin/PI3K signaling 
pathway inhibition.  
(Left) Western blot analysis of IRS1, pP70S6K (T389), P70S6K, pAKT (T308) and AKT 
in RCS chondrocytes treated with vehicle (5% ABS) and FGF18 (50 ng/mL) for 12h. MG132 
was used at 10 µM for 6h to inhibit proteasome activity. β-actin was used as loading control. 
Blots are representative of N=3 independent experiments.  
(Centre) Western blot analysis of IRS1, pP70S6K (T389), P70S6K, pAKT (T308), AKT, 
pcJUN (S73) and cJUN proteins in RCS chondrocytes treated with vehicle (5% ABS) and 
FGF18 (50 ng/mL) for 12h. JNK inhibitor was used at 50 µM for 12h to inhibit kinase 
activity. β-actin was used as loading control. Blots are representative of N=3 independent 
experiments.  
(Right) Co-immunofluorescence of pIRS1 (S307 mouse/S312 human, in green) and pS6 
(S240/S242, in red) ribosomal protein in IRS1-overexpressing RCS chondrocytes treated 
with FGF18 (50 ng/mL) for 12h. Asterisks indicate IRS1-overexpressing cells. Nuclei (N) 
were stained with DAPI (blue). Scale bar 15 µm. Quantification analysis of pS6 ribosomal 
protein fluorescence intensity in IRS1-overexpressing vs non expressing RCS chondrocytes. 
Mean +/- standard error of the mean (sem) of N=3 biological replicates. n=35 cells analyzed. 
Student’s paired T-test *p<0.05. Co-immunofluorescence of TFEB (red) and IRS1 (green) 
in IRS1-overexpressing RCS chondrocytes treated with FGF18 (50 ng/mL) for 12h. 
Asterisks indicate IRS1-overexpressing cells. Nuclei (N) were stained with DAPI (blue). 
Mean +/- standard error of the mean (sem) of N=3 biological replicates. Scale bar 15 µm. 
n= 124 cells analyzed; Student’s un-paired T-test **p<0.005.  
 
A
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Figure 21. FGF signaling activates TFEB/TFE3 through JNK-mediated degradation of 
IRS1.  
(Left) Western blot analysis of IRS1 and phospho-TFEB (S142) in RCS chondrocytes 
treated with vehicle (5% ABS) and FGF18 (50 ng/mL) for 12h. JNK inhibitor was used at 
50 µM for 12h to inhibit kinase activity. β-actin was used as loading control. Representative 
images of N=3 independent experiments.  
(Right) Subcellular localization analysis of TFEB (red) and TFE3 (green) in RCS 
chondrocytes treated with FGF18 (50 ng/mL) for 12h. JNK inhibitor was used at 50 µM for 
12h. Nuclei were stained with DAPI (blue). Quantification analysis showed % of cells with 
nuclear TFEB and TFE3 in RCS chondrocytes with indicated treatments. Mean +/- standard 
error of the mean (sem) of N=3 biological replicates. Scale bar 15 µm. n= 126 cells (control), 
126 cells (FGF18), 95 cells (JNK Inhibitor), 163 cells (JNK Inhibitor + FGF18). Student’s 
paired T-test *p<0.05; **p<0.005. 
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Nutrient starvation promotes mTORC1 inhibition and TFEB nuclear translocation  
Next, we asked whether the TFEB/TFE3 axis was also activated during nutrient and growth 
factor starvation. Starvation with HBSS media induced mTORC1 inhibition, along with 
TFEB nuclear translocation and dephosphorylation (Figure 22), further promoting ER-
phagy via Fam134b transcriptional induction (data not shown). These data overall 
demonstrate that ER-phagy is a process transcriptionally regulated by TFEB and TFE3 
nuclear factors via direct induction of the FAM134B protein, by both starvation and 
stimulation of the FGF signaling pathway in chondrocytes.  
 
 
Figure 22. TFEB/TFE3 axis is activated during starvation.  
(Left) Western blot analysis of pospho-P70S6K (T389), P70S6K, and phospho-TFEB 
(S142) in RCS chondrocytes cultured in complete medium or HBSS for 12h. β-actin was 
used as loading control.  
(Right) Subcellular localization analysis of TFE3 (green) in RCS chondrocytes starved with 
HBSS for 8h. Torin1 was used at 1µM for 2h as positive control. Nuclei were stained with 
DAPI (blue). Quantification analysis showed % of cells with nuclear TFEB and TFE3 in 
RCS chondrocytes with indicated treatments. Mean +/- standard error of the mean (sem) of 
N=3 biological replicates/treatment. Scale bar 10 µm. n= 62 cells (control), 83 cells (HBSS), 
47 cells (Torin1). Analysis of variance one way (ANOVA) p<0.0001; Sidak ‘s multiple 
comparison test ***p<0.0005.  
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Fam134b-Morpholino shows impaired bone mineralization 
Knock-down of Fam134b with a specific morpholino (MO) directed against the second 
splice donor site in the Medaka fish (Oryzias latipes, ol) led to a shorter body length and 
head size with structural abnormalities mainly restricted to bones. Notably, both size and 
mineralization of craniofacial elements that form through endochondral ossification 
(ethmoid plate, palatoquadrate, ceratohyal, paired prootics and fifth ceratobranchial) were 
severely reduced compared with controls (Figure 23). These observations suggest that 
Fam134B-mediated ER-phagy plays a physiological role during endochondral ossification.  
 
 
 
 
 
 
Figure 23. FAM134B knockdown in Medaka embryos is associated to defective 
endochondral ossification. 
(A) qRT-PCR analysis of Fam134b gene in medaka fish with indicated genotypes. Fold 
change values are relative to scramble fish and normalized to Hprt gene. Mean +/- standard 
error of the mean (sem) of N=3 biological replicates. (B) Quantification of total length and 
head size of medaka fish model of Fam134b-morpholino expressed as % relative to the 
scramble. Mean +/- standard error of the mean (sem) of n=9 fish/genotype. Student unpaired 
T-Test *p<0.05. (C) Alcian blue (cartilage) staining of scramble and Fam134b-morpholino 
medaka fish. Graph shows quantification of Ethmoid plate (EP), Palatoquadrate (PQ), 
A B 
C D 
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Ceratohyal (CH), Paired Prootics (PO), Ceretobranchials 1 to 5 (CB1 to CB5) cartilage 
length in Fam134b-morpholino and scramble. Values were expressed as % relative to the 
scramble (100% red dotted line). Mean +/- standard error of the mean (sem) of n=9 
fish/genotype. Student unpaired T-Test*p<0.05; ***p<0.0005. (D) Alizarin Red S (bone) 
staining of scramble and Fam134b morpholino medaka fish. Graph shows quantification of 
Parasphenoid (P), Palatoquadrate (PQ), Ceratohyal (CH), Paired Prootics (PO), 
Ceretobranchials 1 to 5 (CB1 to CB5) mineralization in Fam134b-morpholino. Values were 
expressed as % relative to the scramble (100% red dotted line). Mean +/- standard error of 
the mean (sem) of n=8 fish/genotype. Student unpaired T-Test ***p<0.0005; NS not 
significant. 
 
 
Discussion 
This study has identified a novel signaling pathway that allows ER-phagy responding to both 
metabolic and developmental cues. This work has revealed that the nutrient-regulated 
signaling network downstream TFEB and TFE3 transcription factors respond to extracellular 
cues, such as starvation and FGF signaling.  Specifically, TFEB and TFE3 induce expression 
of lysosomal and autophagy genes and of the ER-phagy receptor FAM134B, hence they 
exert a global enhancement of ER-phagy, from substrate sequestration to autophagic cargo 
delivery and lysosomal degradation.   
TFEB and TFE3 nuclear factors are part of the MiTF/TFE transcription factor family, 
participating to the biogenesis and co-operative functions of AVs and lysosomes, by binding 
of a sequence in the promoter of lysosomal genes, called as Coordinated Lysosomal 
Expression and Regulation (CLEAR) network [91]. The activity of TFEB and TFE3 factors 
is mostly regulated by phosphorylation on different serine residues operated by different 
kinases, such as mTORC1 and AKT [89]. mTORC1 (the Mammalian Target of Rapamycin 
Complex 1) is a serine/threonine phosphatidylinositol-3-kinase-related kinase (PI3K) and it 
covers a central role in the regulation of cellular metabolism and organismal growth. In this 
work, we have identified the mechanism downstream the FGF signaling pathways in 
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chondrocytes. Specifically, we have identified that the FGF signaling induces an inhibition 
of the PI3K signaling via a JNK-mediated degradation of IRS1, a key upstream protein in 
the PI3K signaling pathway [90].  
The process of ER-phagy in chondrocytes overall participates to cell differentiation and 
tissue development. In fact, the lack of Fam134b in Medaka fish shows impaired 
endochondral ossification evidencing how this pathway is likely to play physiologically 
relevant roles in chondrocytes. The observation that starvation and FGF signaling activates 
ER-phagy through same effectors suggests that ER-phagy may participate to regulation of 
energy metabolism in chondrocytes, which reside in a tissue environment characterized by 
scarcity of nutrients, such as the growth plate [92]. During endochondral ossification FGF 
signaling controls chondrocyte hypertrophic differentiation [93, 94], a process that might 
require energy from the degradation of intracellular sources. The discovery of the cellular 
mechanisms governing ER-phagy can be of therapeutic relevance. Thus, the identification 
of the mechanisms controlling ER-phagy might be exploited for the treatment of protein 
conformational diseases. 
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Material and Methods 
Cell Culture, transfections and Plasmids  
RCS were cultured as previously shown. In FGF18 experiments, cells were cultured in 
DMEM supplemented with 5% Adult Bovine Serum (ABS from Bio-Techne). In starvation 
experiment, RCS chondrocytes were cultured in HBSS medium (from Euroclone). For 
transfection experiments: cells were transfected with Lipofectamine LTX and Plus reagent 
(Invitrogen) following reverse transfection protocol according to manufacturer’s 
instructions. Plasmids: human-IRS1- WT plasmid was from Addgene. Chemicals: FGFs 
ligands (Peprotech) were used at 50ng/ml overnight. c-Jun N-Terminal kinase (JNK) 
inhibitor (SP600125, Sigma-Aldrich, Milan, Italy) was used at 50 µM for 12h. Torin1 (Cell 
Signaling) was used at 1 µM for 2h. Proteasomal inhibitor (MG132, Sigma-Aldrich, Milan, 
Italy) was used at 10 µM for 6h.  
 
Immunofluorescence  
RCS chondrocytes were fixed for 15 min in 4% PFA in PBS and permeabilized for 20 min 
in blocking buffer (0.05% (w/v) saponin, 0.5% (w/v) BSA, 50 mM NH4Cl and 0.02% NaN3 
in PBS). Cells were incubated in humid chamber for 1 h at room 22 temperature with primary 
antibodies (p-IRS1 Merck 05-1087 1:100; IRS1 Cell Signaling Technology 2390 1:100; p-
S6 Ribosomal protein Cell Signaling Technology 5364S 1:100), washed three times in PBS, 
incubated for 1 h at room temperature with the secondary (Alexa fluor-labeled 1:400) 
antibodies, washed again three times in PBS, incubated for 20 min with 1µg/ml Hoechst 
33342 and finally mounted in Mowiol. All confocal experiments were acquired using slice 
thickness of 0.5 µm using the LSM 880 confocal microscope equipped with a 63× 1.4 
numerical aperture oil objective. For TFEB and TFE3 immunofluorescence: RCS 
chondrocytes were fixed for 15 min in 4% PFA in PBS and permeabilized for 30 min in 
0.02% Triton X-100 in PBS. Cells were incubated in humid chamber for 1h in Blocking 
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Buffer (0.1% Triton X100, 10% goat serum in PBS) and then with primary antibodies 
overnight at 4°C (TFEB MyBioSource MBS120432 1:50; TFE3 Sigma-Aldrich HPA023881 
1:200) diluted in 0.1% Triton X-100, 5% goat serum in PBS. Alexa-fluor conjugated 
secondary antibodies (1:400) were incubated for 1h at room temperature in 0.1% Triton X-
100, 1% goat serum in PBS. Nuclei were stained with DAPI 1:1000 in PBS for 20 min at 
room temperature. Cells were washed with PBS, once in MilliQ water and mounted with 
Mowiol. All images were captured using LSM 880 confocal microscope equipped with a 
63× 1.4 numerical aperture oil objective. All the quantifications were performed used ImageJ 
plugins.  
 
Western Blotting  
RCS chondrocytes lysates were prepared as previously shown. Protein extracts, separated 
by SDS-PAGE and transferred onto PVDF, were probed with primary antibodies overnight 
against IRS1 (Cell Signaling Technology 2390 1:1000), phospho-P70S6K (Cell Signaling 
Technology 9234S 1:1000), P70S6K (Cell Signaling Technology 9202S 1:1000), phospho-
AKT (Cell Signaling Technology 4056 (T308) - 4060 (S473) 1:1000), AKT (Cell Signaling 
Technology 9272 1:1000), phospho-cJUN (Cell Signaling Technology 2361S 1:1000), 
cJUN (Cell Signaling Technology 9165 1:1000), b-actin (Novus Biologicals 24 NB600-501 
1:5000), TFEB (Bethyl Laboratories A303-673A 1:1000), TFE3 (Sigma-Aldrich 
HPA023881 1:1000), b-tubulin (Sigma T8660 1:10000), phospho-TFEB S142 (ABE1971 
EMD Millipore 1:10000). Proteins of interest were detected with HRP conjugated goat anti-
mouse or anti-rabbit IgG antibody (1: 2000, Vector Laboratories) and visualized with the 
ECL Star Enhanced Chemiluminescent Substrate (Euroclone) according to the 
manufacturer’s protocol. The Western blotting images were acquired using the Chemidoc-lt 
imaging system (UVP).  
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qRT-PCR in Medaka Fishes 
Medaka fishes were pooled for RNA extraction using RNeasy Mini Kit (Cat No./ID: 74106 
(250), Qiagen) according to the manufacturer’s protocol. 1 µg of total RNA was used for 
reverse transcription using QuantiTect Reverse Transcription Kit (Qiagen) according to 
manufacturer’s instructions. qRT-PCR was performed in triplicate using Light Cycler 480 
SYBER Green I Master (Roche) and analyzed by Light Cycler 480 (Roche). The Ct values 
were normalized to Hprt gene and the expression of each gene was represented as 2^(-ddCt) 
relative to control. Primers used were: Fam134b Fw5’-TCACTGCTGGAAGAAACCTG-3’ 
Fam134b Rev5’ –ATCATGAGACGAAACCAGGG-3’. 
 
Medaka stocks  
The Cab-strain of wild type medaka fish (Oryzias latipes) was maintained following standard 
conditions (i.e., 12 h/12 h dark/light conditions at 27 °C). Embryos were staged according 
to [83]. All studies on fish were conducted in strict accordance with the Institutional 
Guidelines for animal research and approved by the Italian Ministry of Health; Department 
of Public Health, Animal Health, Nutrition, and Food Safety in accordance to the law on 
animal experimentation (D.Lgs. 26/2014). Furthermore, all animal treatments were reviewed 
and approved in advance by the Ethics Committee at the TIGEM Institute, (Pozzuoli, NA), 
Italy.  
 
Fam134b morpholino injections  
The available medaka olFam134b (DK136186) genomic sequences were retrieved from 
public databases (http://genome.ucsc.edu/) from human FAM134b (NM_001034850) 
transcript. A morpholino (Mo; Gene Tools LLC, Oregon, USA) was designed against the 
splicing acceptor of exon 2 (MO-Fam134b: 5′- GTCGATGATCTCCCAACTGAAGACA-
3′) of the medaka orthologous of the NEK10 gene. The specificity and inhibitory efficiencies 
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of morpholino was determined as previously described [95]. MO-Fam134b was injected at 
0.015 mM concentration into one blastomere at the one/two-cell stage. Off-target effects of 
the morpholino injections were excluded by repeated experiments with control morpholino 
or by co-injection with a p53 morpholino as previously described [96].  
 
Cartilage and bones staining  
Staining for cartilage (Alcian Blue) and bone (Alizarin Red) in fixed embryos was performed 
according to standard Medaka skeleton phenotyping protocols 
(https://shigen.nig.ac.jp/medaka/medakabook/index.php). Pictures were taken using the 
DM6000 microscopy (Leica Microsystems, Wetzlar, Germany). Measurement of both 
cartilage and bone length was performed using ImageJ. 
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